Search Product
Structure Search
Search
Online Support
-
Customer service
Advantage Products
Location: Industrial Info
China's pharmaceutical excipients market demand soared
2014-07-28
来源：转载自第三方
Over the past five years, the compound annual growth rate of chemical preparations, chemical reagents, Chinese patent drug and biochemical products has reached 24.32%, 24.27% and 31.15% respectively. With the total scale of pharmaceutical preparations to expand year by year, pharmaceutical excipients market demand will rise with the annual rate of 15%~20%. Even estimates of the annual growth rate 15% conservatively, the market size of China's pharmaceutical excipients will reach nearly 40 billion by 2015, showing that its growth space is quite broad.
From the types of excipients, the top ten pharmaceutical excipients in China's market were medicinal gelatin capsules, sucrose, starch, film coating powder, 1,2-propylene glycol, PVP, hydroxypropyl methyl cellulose (HPMC), microcrystalline cellulose, HPC, lactose. China has listed about 500 kinds of excipients, but compared with the United States (more than 1500) and the European Union (more than 3000), the difference is still the poor, the species is still too small, showing that China's pharmaceutical excipients market has a great potential for development.
From view of the form of a drug, oral solid dosage form is the mainstream industry, it is the fastest one: in 2005, the United States, Europe and China's oral solid dosage forms of pharmaceutical excipients market are close to 800 million dollars, sales of 225,000 tons; in 2010, The average annual growth rate of oral solid dosage forms of pharmaceutical excipients in United States, Europe’s are 2.3% and 2.6%, while the average annual growth rate for China is about 8%.
From the proportion of pharmaceutical excipients accounted for pharmaceutical preparations output value, the proportion is 10%~20% in developed countries, but it is only about 2%~3% in China, which proof that China's pharmaceutical excipients industry of the gold growth period is far from over.
International giants have to seize China's pharmaceutical excipients market
China's pharmaceutical excipients market has a huge space for development, and the international tycoon would like to seize this big cake, which shows that China's pharmaceutical excipients industry is definitely not dispensable medicine "supporting role."
Novartis from Switzerland, Meggle Group from Germany, Roquette Freres from France, Colorcon from the USA, and other international professional companies have been landed the market of pharmaceutical excipients via wholly-owned or joint venture approach, most of its brand products are in a monopoly position. On the same species of accessories, the sales of imported products and the average growth rate were significantly higher than domestic products, which is caused by foreign pharmaceutical companies in China generally use the higher standard of imported products. In terms of differentiation, domestic products are mostly traditional materials, while imported products are mostly high-end and new pharmaceutical excipients with higher profit margins, which is because that foreign pharmaceutical excipients enterprises have a strong R & D strength.
As the global patent expires, the generic drugs will enter a fast-growing channel, which will directly lead to the global pharmaceutical market demand for pharmaceutical excipients surge. The international pharmaceutical giants are aiming at this historic opportunity, through the expansion of existing varieties of capacity and M & A competitors to increase the new product line to achieve rapid expansion. At present, the international pharmaceutical giant has made layout of the production base and R & D center in India, the next step they are bound to the Chinese pharmaceutical excipients market which has a broad space for development.
如果涉及转载授权，请联系我们。
